Literature DB >> 27438623

Memantine and Q-VD-OPh Treatments in Experimental Spinal Cord Injury: Combined Inhibition of Necrosis and Apoptosis.

Aydin Aydoseli1, Halil Can, Yavuz Aras, Pulat Akin Sabanci, Mehmet Osman Akcakaya, Omer Faruk Unal.   

Abstract

AIM: To evaluate the effects of NMDA receptor antagonist memantine and pancaspase inhibitor Q-VD-Oph in combination or alone in experimental spinal cord injury.
MATERIAL AND METHODS: 45 male Sprague-Dawley rats were divided into five groups. Spinal cord injury was created with the clip compression technique. The drugs were administered either alone of in combination to the subjects according to their groups. Motor function was assessed with Tarlov's motor grading scale and the inclined plane technique. The subjects were sacrificed at the fifth postoperative day. Histopathological examination was done with the use of hematoxylin eosin and TUNEL staining.
RESULTS: The results for TUNEL staining and apoptotic cell counts revealed statistically significant differences in Q-VD-Oph and combined treatment groups. Tarlov motor grading scale and inclined plane test results were also found significantly better in these two groups.
CONCLUSION: Combined use of memantine and Q-VD-OPh provides better histological and clinical results. The combined inhibition of the two major pathways, necrosis and apoptosis, needs to be further assessed with in-vivo or in-vitro studies.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27438623     DOI: 10.5137/1019-5149.JTN.12999-14.1

Source DB:  PubMed          Journal:  Turk Neurosurg        ISSN: 1019-5149            Impact factor:   1.003


  3 in total

1.  Evaluation of spinal cord protective threshold of serum memantine, an NMDA receptor antagonist, in a rabbit model of paraplegia.

Authors:  Nirmal Panthee; Minoru Ono; Takehito Yamamoto; Masako Ikemura; Tsuruhito Tanaka; Yoshifumi Itoda; Hiroshi Suzuki
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2020-08-21

Review 2.  Spinal Cord Injury: Pathophysiology, Multimolecular Interactions, and Underlying Recovery Mechanisms.

Authors:  Anam Anjum; Muhammad Da'in Yazid; Muhammad Fauzi Daud; Jalilah Idris; Angela Min Hwei Ng; Amaramalar Selvi Naicker; Ohnmar Htwe Rashidah Ismail; Ramesh Kumar Athi Kumar; Yogeswaran Lokanathan
Journal:  Int J Mol Sci       Date:  2020-10-13       Impact factor: 5.923

Review 3.  A long way to go: caspase inhibitors in clinical use.

Authors:  Shanel Dhani; Yun Zhao; Boris Zhivotovsky
Journal:  Cell Death Dis       Date:  2021-10-15       Impact factor: 8.469

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.